Scalpel Versus Laser Gingivectomy in Orthodontic Patients in the Management of Periodontal Health

May 2, 2018 updated by: Andrea Noviello, University of Rome Tor Vergata

Scalpel Versus Laser Gingivectomy in the Management of Periodontal Health During Orthodontic Treatment: a Randomized Controlled Clinical Trial

Patients undergoing orthodontic treatment with fixed appliances usually develop gingival enlargement (GE). Its development is usually attribute to chronic inflammation, and may cause both esthetic and functional problems for the patient. In many cases, the gingival hyperplasia demands periodontal surgery in order to increase the length of the crown during or after the orthodontic treatment. Previously conventional surgical procedures were performed using a scalpel under local anaesthesia for these procedures. Lately the use of laser has been proposed. The majority of the studies comparing laser gingivectomy with scalpel gingivectomy show some limits: they are not randomized, they are not prospective, and they have no control group. The primary objective of the present investigation was to conduct a randomized controlled trial (RCT) evaluating the effectiveness of diode laser gingivectomy versus scalpel gingivectomy in the management of periodontal health among patients receiving fixed orthodontic appliance therapy, compared with a non surgical control group.

Study Overview

Detailed Description

Gingival enlargement (GE) is one of the most common soft tissue problems in patients undergoing orthodontic fixed treatment, particularly when spaces are rapidly closed and oral hygiene is poor. The mechanism by which GE occurs during orthodontic treatment is not fully understood. The initiation and development of periodontal disease depend on a dynamic equilibrium between the microbial challenge and the host's immune-inflammatory responses. The presence of fixed appliances influences plaque accumulation around the retentive components attached to the teeth and the colonization of important periodontopathic bacteria. Chronic inflammation of the soft tissues is caused by a significant increase in edema and inflammatory cells that can influence the sub-gingival ecosystem by creating an appropriate anaerobic environment, leading to a shift in the composition of the microflora. When gingival tissues are enlarged, varying from mild enlargement of isolated interdental papillae to segmental or uniform and marked enlargement affecting one or both jaws, the tooth surfaces become difficult to access, inhibiting good oral hygiene and resulting in more inflammation and bleeding because enlarged gingival tissues. In artificially deeper periodontal pockets, the root surfaces are contaminated with an accumulation of plaque and calculus, as well as infiltration of bacteria and bacterial endotoxins into cementum. Complete removal of these harmful substances is essential for the healing of periodontal tissue. However, nonsurgical periodontal treatment (including oral hygiene instruction, scaling, root planing, and prophylaxis) is not always effective when GE is extensive and self-care is compromised. When GE further impedes the maintenance of oral hygiene (thereby resulting in further damage to periodontal tissues), causes aesthetic and functional problems, and compromises orthodontic tooth movement, it is necessary to provide additional surgery treatment such as gingivectomy, in order to correct gingival border contours. Gingivectomy can be performed by conventional scalpels, electrosurgery, chemosurgery, and laser. Preservation of biologic width is the therapeutic endpoint of all these procedures. 3 mm of tooth structure above the osseous crest is considered safe to prevent any attachment loss. The conventional surgery performed by a small scalpel has been considered the most common method because of its ease of use, accuracy, and minimal damage to tissues. However, scalpels do not provide a good hemostasis, which is important on highly perfused tissues such as in the oral cavity. The advent of diode lasers highly absorbable by melanin and hemoglobin allows soft-tissue manipulations providing sound results in periodontal surgery, tissue alterations related to orthodontic treatment, and oral lesions. The diode laser separates and coagulates at the same time, facilitating immediate hemostasis and resulting in minimal bleeding. Healing is rapid and there is reduced potential for infection. The diode laser has an affinity for only soft tissue, thereby preventing damage to the surrounding bone and enamel. Therefore, using diode lasers might be advantageous because of better control, potentially lower pain and inflammation, and improved wound healing. In literature, no studies directly compared conventional scalpel surgery versus diode laser-assisted surgery in orthodontic patients with GE. Moreover, the majority of the studies comparing laser gingivectomy with scalpel gingivectomy show some limits: they are not randomized, they are not prospective, and they have no control group. Therefore, the aim of the present study was to compare the use of the 810nm diode laser with conventional surgery and to evaluate the effectiveness of gingivectomy as an adjunct to nonsurgical periodontal treatment in the management of GE during orthodontic treatment. The Consolidated Standards of Reporting Trials (CONSORT) checklist was used as a guideline for conducting and reporting this trial. The present Randomized Clinical Trial was designed as a prospective three-arm parallel group randomized clinical trial with 1:1:1 allocation ratio. The study was approved by the Ethics Committee at the University of Rome "Tor Vergata", (protocol number 206/17), and informed consent was obtained from the patients' parents. A total of 60 (33 Males; 27 Females) subjects, with a mean age of 14.4 ± 1.9 years (range 11.7-19.8 years), undergoing orthodontic treatment at the Department of Orthodontic of the University of Rome "Tor Vergata" were recruited for the study. Gingival overgrowth diagnosis was defined as presence of quadratic anterior teeth (crown width/length ratio ≤0.85), gingival margin located incisal to the tooth cervical convexity and presence of mean Probing Pocket Depths (PPD) ≥ 4mm coronal to the cement-enamel junction (CEJ) at three buccal points around each tooth of the anterior segment (mesial, mid-point, distal). Crown Width (CW) and Clinical Crown Length (CCL) were measured pre-operatively with a digital caliper: CCL, measured as the distance between incisal edge and gingival margin along the tooth long axis; CW measured at the point between incisal and middle third of CCL. All subjects received ongoing nonsurgical periodontal treatment and instructions on oral hygiene. After the conventional management approach for gingival enlargement, patients with persistent gingival overgrowth were enrolled in the study and blindly assigned to three groups. In the first group (TG1), all subjects underwent a conventional scalpel gingivectomy of the maxillary anterior sextant. In the second group (TG2), all subjects were treated using laser-assisted gingivectomy; while subjects assigned to the third group underwent only nonsurgical periodontal treatment and served as the control group (CG). Both TGs were consecutively treated by one clinician. The PPDs were recorded to determine the biologic width and to assess how much tissue could be contoured without involving osseous surgery, using a North Carolina periodontal probe. Remembering that there exists a 3.0 mm biologic zone, the maximum amount of tissue removal could be calculated. The periodontal probe was placed apically to the alveolar crest, and the marginal gingival level was measured. An explorer was used to mark reference spots of the biologic zone, serving as the visual finishing point. At baseline (before surgery) all patients of the three groups underwent a full periodontal screening. Their oral hygiene and gingival inflammation were assessed using CCL, PPD, Plaque Index (PI) and Gingival Index (GI) at three buccal points around each tooth of the anterior segment (mesial, mid-point, distal). All measures were repeated at 1, 3 and 6 months post-surgery or nonsurgical periodontal treatment. Overall patient data were calculated as mean value by averaging measurements in all sites of six upper anterior teeth. A sample size for this trial was calculated according to the method proposed by Whitehead et al. For a standardized effect size of 1 (a clinically relevant change of 0.75 mm with a combined SD of 0.68 mm derived from Mavroggianis et al.) for the primary outcome variable PPD at 3 months, a sample size of 17 subjects per group was required for a type I error rate of 5% and a power of 80%. To account for potential dropouts, 20 subjects per group were recruited. Allocation of patients to the three groups was determined by a computer-generated randomization list using Rv.0.1 software and by a block size of 4. Then, the allocation information (randomization results) was concealed in opaque and sealed envelopes by the statistician. The observer who performed all the measurements was blinded to the group assignment. The study was blinded in regard to the statistical analysis: blinding was obtained by eliminating from the elaboration file every reference to patient group assignment. Reliability of the periodontal assessments was conducted among 10 patients throughout the study. Exploratory statistics revealed that all periodontal variables were normally distributed (Kolmogorov-Smirnov test) with equality of variances (Levene's test). All statistical computations were performed with SPSS software (Statistical Package for the Social Sciences, SPSS, Version 12, Chicago, IL, USA).

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Roma, Italy, 00133
        • Department of Orthodontics, Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata".

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 23 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • overgrown gingivae on the labial side of the anterior teeth secondary to fixed appliance therapy,
  • six maxillary anterior teeth present,
  • healthy nonsmokers patients.

Exclusion Criteria:

  • patients with poor oral hygiene;
  • patients with mucogingival infection;
  • patients taking medications that may cause drug-associated gingival enlargement (eg. calcium channel blockers, anticonvulsants, or immunosuppressants)
  • patients currently pregnant or lactating;
  • patients with any medical condition affecting wound healing.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Scalpel Gingivectomy
Patients treated with Scalpel Gingivectomy on the labial side of the anterior maxillary teeth
The patients were anesthetized in the area around the teeth which were to undergo the procedure with local anesthesia (Drug: 2% lidocaine and 1:80,000 adrenaline). Initially, the Periodontal Probing Depth was measured and when sufficient anesthesia was achieved, biologic width calculation was done by the trans-gingival probing method. Once the amount of gingival tissue to be excised was demarcated, an external bevel incision was performed by using a scalpel blade (Device: scalpel blade No.15) and the gingival tissue was excised. Left out tissue tags and any beads of granulations tissue were removed to attain a smooth surface.
Active Comparator: Laser Gingivectomy
Patients treated with Laser Gingivectomy on the labial side of the anterior maxillary teeth
In the Laser Gingivectomy group, the procedure was performed by using a 810 nm diode laser (Device: 810 nm FOX III diode laser) . Though a local anesthetic gel is sufficient considering that the procedure is minimally invasive, the area was adequately anesthetized with 2% lidocaine and 1:80,000 adrenaline. The laser unit, comprising of a 300 μm disposable tip, was used in a contact mode with a setting of 1 to 1.5 watts in continuous mode along the demarcated area with a paint brush like strokes progressing slowly to remove the gingival tissue and expose adequate amount of tooth structure. High-volume suction was used to evacuate the laser plume and charred odor
Active Comparator: Nonsurgical periodontal treatment
Patients treated with a full-mouth periodontal debridement
In all subjects of the Control Group a full-mouth periodontal debridement was performed at baseline, 1 and 3 months with an ultrasonic scaler. Chlorhexidine prophylaxis (0.05% chlorhexidine gluconate) was also administered twice a day for 2 weeks after the periodontal treatment. Oral-hygiene instructions were reinforced again.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing Pocket Depth Changes after Scalpel Gingivectomy vs Laser Gingivectomy compared with a Control Group receiving non surgical periodontal treatment only at 3 time points respect to baseline.
Time Frame: 6 months

The primary outcome is the reduction of the Pocket Depth. The objective is to evaluate the change in the Pocket Depth induced by Scalpel Gingivectomy or Laser Gingivectomy, compared with a nonsurgical periodontal treatment group at 3 time points respect to baseline: 1 month, 3 months and 6 months.

Probing Pocket Depths (PPDs) were recorded at baseline to determine the biologic width and to assess how much tissue could be contoured without involving osseous surgery, using a North Carolina periodontal probe; Scalpel Gingivectomy or Laser Gingivectomy were performed in the treated groups.

In the non surgical periodontal treatment group, full-mouth periodontal debridement was performed at baseline, 1 and 3 months with an ultrasonic scaler.

Overall patient data were calculated as mean value by averaging measurements in all sites of six upper anterior teeth.

6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Increased Clinical Crown Length (CCL) after Scalpel Gingivectomy vs Laser Gingivectomy
Time Frame: 6 months

The secondary outcome is the increase of the CCL, measured as the distance between incisal edge and gingival margin along the tooth long axis.

The objective is to evaluate the change in the CCL induced by Scalpel Gingivectomy or Laser Gingivectomy, compared with a nonsurgical periodontal treatment group.

All measures were repeated at 1, 3 and 6 months post-surgery or full-mouth periodontal debridement. Overall patient data were calculated as mean value by averaging measurements of six upper anterior teeth.

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Noviello, Department of Orthodontics, Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata," Rome, Italy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

February 28, 2018

Study Completion (Actual)

February 28, 2018

Study Registration Dates

First Submitted

April 11, 2018

First Submitted That Met QC Criteria

April 19, 2018

First Posted (Actual)

May 2, 2018

Study Record Updates

Last Update Posted (Actual)

May 8, 2018

Last Update Submitted That Met QC Criteria

May 2, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthodontic Appliance Complication

Clinical Trials on Scalpel Gingivectomy

3
Subscribe